A tanned red cell hemagglutination inhibition immunoassay (TRCHII) for the quantitative estimation of thrombin-antithrombin III and plasmin-alpha1-antiplasmin complexes in human plasma. - Suppr | 超能文献

A tanned red cell hemagglutination inhibition immunoassay (TRCHII) for the quantitative estimation of thrombin-antithrombin III and plasmin-alpha1-antiplasmin complexes in human plasma.

作者信息

Collen D, De Cock F

出版信息

Thromb Res. 1975 Jul;7(1):235-8. doi: 10.1016/0049-3848(75)90140-1.

DOI:10.1016/0049-3848(75)90140-1

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

A tanned red cell hemagglutination inhibition immunoassay (TRCHII) for the quantitative estimation of thrombin-antithrombin III and plasmin-alpha1-antiplasmin complexes in human plasma.

Thromb Res. 1975 Jul;7(1):235-8. doi: 10.1016/0049-3848(75)90140-1.

2

Emergence in plasma during activation of the coagulation or fibrinolytic systems of neoantigens, associated with the complexes of thrombin or plasmin with their inhibitors.在凝血或纤维蛋白溶解系统激活过程中，新抗原在血浆中出现，这些新抗原与凝血酶或纤溶酶及其抑制剂的复合物相关。

Thromb Res. 1974 Dec;5(6):777-9. doi: 10.1016/0049-3848(74)90121-2.

3

The immunochemical determination of thrombin-antithrombin III and plasmin-antiplasmin complexes in human plasma.

Verh K Acad Geneeskd Belg. 1979;41(2):81-166.

4

[Hemostatic tests for the diagnosis of thrombosis. Activated coagulation and fibrinolytic factors. Detection of the protease/inhibitor complex].

Rinsho Byori. 1988 Jun;36(6):623-6.

5

Thrombin-antithrombin III and plasmin-antiplasmin complexes as indicators of in vivo activation of the coagulation and/or fibrinolytic systems.凝血酶 - 抗凝血酶III复合物和纤溶酶 - 抗纤溶酶复合物作为体内凝血和/或纤维蛋白溶解系统激活的指标。

Acta Clin Belg. 1977;32(6):398-402. doi: 10.1080/17843286.1977.11717894.

6

[Studies on the process of fibrinogen breakdown by plasmin. II. Relationship between serial thrombin time and plasma antithrombin or antiplasmin].[纤溶酶分解纤维蛋白原过程的研究。II. 连续凝血酶时间与血浆抗凝血酶或抗纤溶酶之间的关系]

Nihon Naika Gakkai Zasshi. 1970 Sep;59(9):959-66.

7

[Antithrombin III and alpha 2-plasmin inhibitor in DIC--the significance of their levels and existence of complexes as diagnostic indicators].[抗凝血酶III和α2-纤溶酶抑制剂在弥散性血管内凝血中的作用——其水平及复合物存在情况作为诊断指标的意义]

Rinsho Ketsueki. 1985 Mar;26(3):332-40.

8

Imbalance between thrombin and plasmin activity in disseminated intravascular coagulation. Assessment by the thrombin-antithrombin-III complex/plasmin-alpha-2-antiplasmin complex ratio.弥散性血管内凝血中凝血酶与纤溶酶活性的失衡。通过凝血酶 - 抗凝血酶 - III复合物/纤溶酶 - α2 - 抗纤溶酶复合物比值进行评估。

Haemostasis. 1992;22(4):179-86. doi: 10.1159/000216317.

9

[Thrombin, antithrombin, thrombin-antithrombin complex (TAT)].[凝血酶、抗凝血酶、凝血酶 - 抗凝血酶复合物（TAT）]

Nihon Rinsho. 2004 Dec;62 Suppl 12:626-8.

10

The coagulation system is activated in idiopathic cardiomyopathy.凝血系统在特发性心肌病中被激活。

J Am Coll Cardiol. 1995 Jun;25(7):1634-40. doi: 10.1016/0735-1097(95)00049-a.

引用本文的文献

1

Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injury.凝血酶是患有内皮损伤的犬类冠状动脉狭窄中血小板聚集的重要介质。

J Clin Invest. 1989 Jul;84(1):18-27. doi: 10.1172/JCI114138.

2

Inhibition of plasmin by fibrinogen.纤维蛋白原对纤溶酶的抑制作用。

Biochem J. 1990 Jul 15;269(2):299-302. doi: 10.1042/bj2690299.